0 CHECKOUT

Dermatitis - Pipeline Review, H1 2015

  • ID: 3164991
  • March 2015
  • 381 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • AlbireoPharma
  • ChemoCentryx, Inc.
  • Fountain Biopharma Inc.
  • LEO Pharma A/S
  • Nuvo Research Inc.
  • Promius Pharma, LLC
  • MORE

Dermatitis - Pipeline Review, H1 2015

Summary

This, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dermatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dermatitis and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AlbireoPharma
  • ChemoCentryx, Inc.
  • Fountain Biopharma Inc.
  • LEO Pharma A/S
  • Nuvo Research Inc.
  • Promius Pharma, LLC
  • MORE

Introduction
Dermatitis Overview
Therapeutics Development
Dermatitis - Therapeutics under Development by Companies
Dermatitis - Therapeutics under Investigation by Universities/Institutes
Dermatitis - Pipeline Products Glance
Dermatitis - Products under Development by Companies
Dermatitis - Products under Investigation by Universities/Institutes
Dermatitis - Companies Involved in Therapeutics Development
Dermatitis - Therapeutics Assessment
Drug Profiles
Dermatitis - Recent Pipeline Updates
Dermatitis - Dormant Projects
Dermatitis - Discontinued Products
Dermatitis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Dermatitis, H1 2015
Number of Products under Development for Dermatitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Development by Companies, H1 2015 (Contd..8)
Products under Investigation by Universities/Institutes, H1 2015
Dermatitis - Pipeline by AlbireoPharma, H1 2015
Dermatitis - Pipeline by Amorepacific Corporation, H1 2015
Dermatitis - Pipeline by Anacor Pharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by AnaMar AB, H1 2015
Dermatitis - Pipeline by AnaptysBio, Inc., H1 2015
Dermatitis - Pipeline by AnGes MG, Inc., H1 2015
Dermatitis - Pipeline by Aquinox Pharmaceuticals Inc., H1 2015
Dermatitis - Pipeline by arGEN-X BV, H1 2015
Dermatitis - Pipeline by Biomar Microbial Technologies, H1 2015
Dermatitis - Pipeline by Blueberry Therapeutics Ltd, H1 2015
Dermatitis - Pipeline by Brickell Biotech, Inc., H1 2015
Dermatitis - Pipeline by Bristol-Myers Squibb Company, H1 2015
Dermatitis - Pipeline by Celgene Corporation, H1 2015
Dermatitis - Pipeline by Celsus Therapeutics Plc, H1 2015
Dermatitis - Pipeline by ChemoCentryx, Inc., H1 2015
Dermatitis - Pipeline by China Biologic Products, Inc., H1 2015
Dermatitis - Pipeline by ChironWells GmbH, H1 2015
Dermatitis - Pipeline by Chugai Pharmaceutical Co., Ltd., H1 2015
Dermatitis - Pipeline by Circassia Pharmaceuticals plc, H1 2015
Dermatitis - Pipeline by Convoy Therapeutics, Inc., H1 2015
Dermatitis - Pipeline by Creabilis SA, H1 2015
Dermatitis - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Dermatitis - Pipeline by Dermira Inc., H1 2015
Dermatitis - Pipeline by Eisai Co., Ltd., H1 2015
Dermatitis - Pipeline by EpiPharm AG, H1 2015
Dermatitis - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Dermatitis - Pipeline by FAES Farma SA, H1 2015
Dermatitis - Pipeline by Foamix Pharmaceuticals Ltd., H1 2015
Dermatitis - Pipeline by Fountain Biopharma Inc., H1 2015
Dermatitis - Pipeline by GlaxoSmithKline plc, H1 2015
Dermatitis - Pipeline by GlycaNova Norway AS, H1 2015
Dermatitis - Pipeline by Grupo Ferrer Internacional, S.A., H1 2015
Dermatitis - Pipeline by Han Wha Pharma Co., Ltd., H1 2015
Dermatitis - Pipeline by HanAll Biopharma Co., Ltd., H1 2015
Dermatitis - Pipeline by Herantis Pharma plc., H1 2015
Dermatitis - Pipeline by IMMD Inc., H1 2015
Dermatitis - Pipeline by Immune Response BioPharma, Inc., H1 2015
Dermatitis - Pipeline by Inflamalps SA, H1 2015
Dermatitis - Pipeline by Janssen Research & Development, LLC, H1 2015
Dermatitis - Pipeline by Johnson & Johnson, H1 2015
Dermatitis - Pipeline by Kyowa Hakko Kirin Co., Ltd., H1 2015
Dermatitis - Pipeline by LegoChem Biosciences, Inc, H1 2015
Dermatitis - Pipeline by LEO Pharma A/S, H1 2015
Dermatitis - Pipeline by Lixte Biotechnology Holdings, Inc., H1 2015
Dermatitis - Pipeline by Madam Therapeutics B.V., H1 2015
Dermatitis - Pipeline by Marinomed Biotechnologie GmbH, H1 2015
Dermatitis - Pipeline by Maruho Co., Ltd., H1 2015
Dermatitis - Pipeline by MedImmune, LLC, H1 2015
Dermatitis - Pipeline by Merck & Co., Inc., H1 2015
Dermatitis - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Dermatitis - Pipeline by Nabriva Therapeutics AG, H1 2015
Dermatitis - Pipeline by NeoPharm Co., Ltd., H1 2015
Dermatitis - Pipeline by Novan, Inc., H1 2015
Dermatitis - Pipeline by Novartis AG, H1 2015
Dermatitis - Pipeline by Nuvo Research Inc., H1 2015
Dermatitis - Pipeline by Otsuka Holdings Co., Ltd., H1 2015
Dermatitis - Pipeline by Oxagen Limited, H1 2015
Dermatitis - Pipeline by Pergamum AB, H1 2015
Dermatitis - Pipeline by Pfizer Inc., H1 2015
Dermatitis - Pipeline by Pharis Biotec GmbH, H1 2015
Dermatitis - Pipeline by Pharmedartis GmbH, H1 2015
Dermatitis - Pipeline by Phosphagenics Limited, H1 2015
Dermatitis - Pipeline by ProCertus BioPharm Inc., H1 2015
Dermatitis - Pipeline by Promius Pharma, LLC, H1 2015
Dermatitis - Pipeline by Provectus Biopharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by R-Tech Ueno, Ltd., H1 2015
Dermatitis - Pipeline by Reata Pharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by Regeneron Pharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by RestorGenex Corporation, H1 2015
Dermatitis - Pipeline by Stemnion, Inc, H1 2015
Dermatitis - Pipeline by sterna biologicals Gmbh & Co KG, H1 2015
Dermatitis - Pipeline by Sun Pharma Advanced Research Company Ltd., H1 2015
Dermatitis - Pipeline by SWITCH Biotech LLC, H1 2015
Dermatitis - Pipeline by Taisho Pharmaceutical Co., Ltd., H1 2015
Dermatitis - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
Dermatitis - Pipeline by Thesan Pharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by Upsher-Smith Laboratories, Inc., H1 2015
Dermatitis - Pipeline by Valeant Pharmaceuticals International, Inc., H1 2015
Dermatitis - Pipeline by Vicore Pharma AB, H1 2015
Dermatitis - Pipeline by Vida Therapeutics Inc., H1 2015
Dermatitis - Pipeline by Vitae Pharmaceuticals, Inc., H1 2015
Dermatitis - Pipeline by VivaCell Biotechnology Espana S.L., H1 2015
Dermatitis - Pipeline by Welichem Biotech Inc., H1 2015
Dermatitis - Pipeline by XBiotech USA, Inc., H1 2015
Dermatitis - Pipeline by Xencor, Inc., H1 2015
Dermatitis - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015
Dermatitis - Pipeline by Ziarco Pharma Ltd, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Dermatitis Therapeutics - Recent Pipeline Updates, H1 2015
Dermatitis - Dormant Projects, H1 2015
Dermatitis - Dormant Projects (Contd..1), H1 2015
Dermatitis - Dormant Projects (Contd..2), H1 2015
Dermatitis - Dormant Projects (Contd..3), H1 2015
Dermatitis - Dormant Projects (Contd..4), H1 2015
Dermatitis - Dormant Projects (Contd..5), H1 2015
Dermatitis - Dormant Projects (Contd..6), H1 2015
Dermatitis - Dormant Projects (Contd..7), H1 2015
Dermatitis - Dormant Projects (Contd..8), H1 2015
Dermatitis - Dormant Projects (Contd..9), H1 2015
Dermatitis - Dormant Projects (Contd..10), H1 2015
Dermatitis - Dormant Projects (Contd..11), H1 2015
Dermatitis - Dormant Projects (Contd..12), H1 2015
Dermatitis - Discontinued Products, H1 2015
Dermatitis - Discontinued Products (Contd..1), H1 2015

List of Figures
Number of Products under Development for Dermatitis, H1 2015
Number of Products under Development for Dermatitis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

AlbireoPharma
Amorepacific Corporation
Anacor Pharmaceuticals, Inc.
AnaMar AB
AnaptysBio, Inc.
AnGes MG, Inc.
Aquinox Pharmaceuticals Inc.
arGEN-X BV
Biomar Microbial Technologies
Blueberry Therapeutics Ltd
Brickell Biotech, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Celsus Therapeutics Plc
ChemoCentryx, Inc.
China Biologic Products, Inc.
ChironWells GmbH
Chugai Pharmaceutical Co., Ltd.
Circassia Pharmaceuticals plc
Convoy Therapeutics, Inc.
Creabilis SA
Daiichi Sankyo Company, Limited
Dermira Inc.
Eisai Co., Ltd.
EpiPharm AG
F. Hoffmann-La Roche Ltd.
FAES Farma SA
Foamix Pharmaceuticals Ltd.
Fountain Biopharma Inc.
GlaxoSmithKline plc
GlycaNova Norway AS
Grupo Ferrer Internacional, S.A.
Han Wha Pharma Co., Ltd.
HanAll Biopharma Co., Ltd.
Herantis Pharma plc.
IMMD Inc.
Immune Response BioPharma, Inc.
Inflamalps SA
Janssen Research & Development, LLC
Johnson & Johnson
Kyowa Hakko Kirin Co., Ltd.
LegoChem Biosciences, Inc
LEO Pharma A/S
Lixte Biotechnology Holdings, Inc.
Madam Therapeutics B.V.
Marinomed Biotechnologie GmbH
Maruho Co., Ltd.
MedImmune, LLC
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Nabriva Therapeutics AG
NeoPharm Co., Ltd.
Novan, Inc.
Novartis AG
Nuvo Research Inc.
Otsuka Holdings Co., Ltd.
Oxagen Limited
Pergamum AB
Pfizer Inc.
Pharis Biotec GmbH
Pharmedartis GmbH
Phosphagenics Limited
ProCertus BioPharm Inc.
Promius Pharma, LLC
Provectus Biopharmaceuticals, Inc.
R-Tech Ueno, Ltd.
Reata Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
RestorGenex Corporation
Stemnion, Inc
sterna biologicals Gmbh & Co KG
Sun Pharma Advanced Research Company Ltd.
SWITCH Biotech LLC
Taisho Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Thesan Pharmaceuticals, Inc.
Upsher-Smith Laboratories, Inc.
Valeant Pharmaceuticals International, Inc.
Vicore Pharma AB
Vida Therapeutics Inc.
Vitae Pharmaceuticals, Inc.
VivaCell Biotechnology Espana S.L.
Welichem Biotech Inc.
XBiotech USA, Inc.
Xencor, Inc.
Yungjin Pharm Ind. Co., Ltd.
Ziarco Pharma Ltd

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Merck & Co., Inc.
  • Celgene Corporation
  • GlaxoSmithKline PLC
  • Genentech, Inc.
  • Johnson & Johnson Services, Inc.
  • ViiV Healthcare